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circulating vitamin D and parathyroid
hormone identifies novel loci in Alaska
Native Yup’ik people
Stella Aslibekyan1, Laura K. Vaughan2,4, Howard W. Wiener1, Bertha A. Hidalgo1, Dominick J. Lemas3,
Diane M. O’Brien5, Scarlett E. Hopkins5, Kimber L. Stanhope6, Peter J. Havel6, Kenneth E. Thummel7,
Bert B. Boyer5 and Hemant K. Tiwari2*Abstract
Background: Vitamin D deficiency is a well-documented public health issue with both genetic and environmental
determinants. Populations living at far northern latitudes are vulnerable to vitamin D deficiency and its health sequelae,
although consumption of traditional native dietary pattern rich in fish and marine mammals may buffer the effects of
reduced sunlight exposure. To date, few studies have investigated the genetics of vitamin D metabolism in circumpolar
populations or considered genediet interactions with fish and n-3 fatty acid intake.
Methods: We searched for genomic regions exhibiting linkage and association with circulating levels of vitamin D and
parathyroid hormone (PTH) in 982 Yup’ik individuals from the Center for Alaska Native Health Research Study. We also
investigated potential interactions between genetic variants and a biomarker of traditional dietary intake, the δ15N value.
Results: We identified several novel regions linked with circulating vitamin D and PTH as well as replicated a previous
linkage finding on 2p16.2 for vitamin D. Bioinformatic analysis revealed multiple candidate genes for both PTH and
vitamin D, including CUBN, MGAT3, and NFKBIA. Targeted association analysis identified NEBL as a candidate gene for
vitamin D and FNDC3B for PTH. We observed significant associations between a variant in MXD1 and vitamin D only
when an interaction with the δ15N value was included. Finally, we integrated pathway level information to illustrate the
biological validity of the proposed candidate genes.
Conclusion: We provide evidence of linkage between several biologically plausible genomic regions and vitamin D
metabolism in a circumpolar population. Additionally, these findings suggest that a traditional dietary pattern may
modulate genetic effects on circulating vitamin D.
Keywords: Alaska Native, Vitamin D, Linkage, n-3 fatty acids, Parathyroid hormoneBackground
Vitamin D, a steroid hormone synthesized in the skin or
acquired through diet, and parathyroid hormone (PTH),
secreted by parathyroid glands, work synergistically to
promote absorption of dietary calcium and phosphates
(reviewed by [31]). In addition, vitamin D affects cell cycle,
proliferation, differentiation, and apoptosis through vitamin D* Correspondence: htiwari@uab.edu
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(http://creativecommons.org/publicdomain/zereceptor response elements found on several hundred genes
(reviewed by [40]). As a consequence of its physiological im-
portance, a large body of evidence links circulating vitamin D
to numerous health outcomes, including skeletal health,
cardiovascular disease, type 1 diabetes, type 2 diabetes, meta-
bolic syndrome, autoimmune diseases, multiple sclerosis, and
some types of cancer ([22], reviewed by [15, 16]).
The primary form of circulating vitamin D, 25-hydroxy-
vitamin D (25(OH)D), is converted to the metabolically
active form 1,25-dihydroxy-vitamin D (1,25(OH)2D). The
conversion is regulated by PTH as part of a feedbackle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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(reviewed by [13, 17, 31]). Concentrations of 25(OH)D in
the blood, which aggregately reflect endogenous generation
through UVB exposure (D3), exogenous dietary intake (D3
from animal sources, D2 from plant sources), and supple-
mentation, are considered the best indicator of vitamin D
status (reviewed by [50]). In addition to the environmental
inputs of sunlight and diet, high inter-individual variation in
circulating 25(OH)D as well as family studies suggest a role
for genetic determinants [1, 14]. Large-scale genome-wide
association studies (GWAS) of 25(OH)D have confirmed
associations with polymorphisms near cholesterol synthesis,
hydroxylation, and vitamin D transport genes in individuals
of European descent [1, 46]. Despite the documented im-
portance of ancestry to vitamin D status [42, 46], genetic
risk factors for other populations are less established.
Of particular salience is the study of vitamin D in Arctic
populations, where exposure to sunlight is greatly reduced
for at least half of the year (reviewed in [15]). However,
this deficit may be corrected by traditional subsistence
diets that are rich in vitamin D due to high intake of fish
such as salmon or halibut and marine mammals. Further-
more, there is evidence of physiological adaptations lead-
ing to more efficient calcium absorption. For example, in
Greenland Inuit people, vitamin D is produced at a lower
rate than in Europeans, but the rate of PTH-mediated
conversion to 1,25(OH)2D is higher [37]. Another study
documented normal serum calcium despite low 25(OH)D
and dietary calcium in Canadian Inuit children, postulat-
ing that evolutionary pressures have selected for vitamin
D receptors that bind more strongly to the vitamin D mol-
ecule [10, 41]. For these reasons, investigating genetic
determinants of vitamin D and PTH in Arctic popula-
tions, as well as gene-diet interactions with the intake of
vitamin D-rich fatty fish, is likely to yield unique insights.
To that end, we performed the first genome-wide link-
age analysis of both 25(OH)D and PTH in a population
of Yup’ik people participating in the Center for Alaska
Native Health Research (CANHR) study. We followed
up our findings with targeted association and gene-diet
interaction analyses and used complementary bioinfor-
matic tools to identify putative genetic contributors to
vitamin D and PTH homeostasis in this community.
Methods
The CANHR population and study sample
The CANHR studies genetic, behavioral, and nutritional
risk factors for obesity and related cardiometabolic
diseases among Yup’ik people in a community-based set-
ting [29]. Recruitment of Yup’ik families was initiated in
2003 and continues in 11 Southwest Alaskan communi-
ties, where all residents are invited to participate, result-
ing in a convenience sample. The present study sample
was comprised of 982 non-pregnant Yup’ik individuals(age range, 131–94) and were informative for genetic
linkage analysis; of those, 926 passed quality control
checks and had either 25(OH)D or PTH measurements
or both. All participants signed informed consent docu-
ments, and the study protocols were approved by the
Institutional Review Boards of the University of Alaska
and the National and Alaska Area Indian Health Service
Institutional Review Boards, as well as the Yukon Kusko-
kwim Human Studies Committee.Laboratory measurements
Blood samples were collected from participants after an
overnight fast and were immediately processed in the
field, stored at −15 °C for up to a week, and then stored
at −80 °C at the University of Alaska Fairbanks [5]. Total
25(OH)D was ascertained through a quantitative chemi-
luminescent immunoassay (ARUP Laboratories, Salt
Lake City, UT). This assay accurately quantifies the sum
of 25(OH)D3 and 25(OH)D2. The intra- and inter-assay
coefficients of variation (CVs) were 5.5 and 12.7 %, re-
spectively. ARUP participates in the College of American
Pathologists Laboratory Accreditation Program and has
CLIA (Clinical Laboratory Improvement Amendments)
certification through the Centers of Medicare and Me-
dicaid Services. PTH levels were assayed at the Univer-
sity of California at Davis using the DSL-8000 ACTIVE®
Intact PTH IRMA Kit (Diagnostic Systems Laboratories,
Inc., Webster, TX). The procedure employs a two-site
immuno-radiometric assay principle [28]. The intra- and
inter-assay CVs were 4.2 and 10.3 %, respectively. Trad-
itional dietary intake was assessed using red blood cell
(RBC) nitrogen stable isotope ratios (15N/14N) as previ-
ously described [34] and validated [30]. By convention,
isotope ratios were expressed in relative abundance
using delta values, as follows: δ15N = (15N/14Nsample −
15N/14Nstd)/
15N/14Nstd × 1000‰, in which the standard
is atmospheric nitrogen (15N/14N = 0.0036765). Analyt-
ical precision as assessed using reference materials was
within 0.2‰.Genotyping and quality control
Detailed descriptions of genotyping procedures, pedigree
analyses, and data cleaning have previously been pub-
lished [3]. Briefly, genotyping at 6090 loci was performed
at the Center for Inherited Disease Research at Johns
Hopkins University using the Illumina Linkage-IV panel
(Illumina, San Diego, CA, USA), spanning the entire
genome with an average genetic distance of 0.58 cM.
Due to residual kurtosis following trait transformation,
all linkage analyses involving vitamin D levels used
the t-distribution option in Sequential Oligogenic
Linkage Analysis Routines (SOLAR) to control type I
error rate [2].
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measures, specifically the removal of single nucleotide
polymorphisms (SNPs) exhibiting inconsistencies with
Mendelian segregation or Hardy-Weinberg equilibrium,
prior to whole-genome linkage analysis as previously de-
scribed [3]. Variants that passed quality checks were used
to ascertain a cryptic population substructure, deriving
“community group” as a dichotomous covariate indicating
proximity to the coast.
Linkage and association analysis
We estimated the heritability and conducted a whole-
genome linkage scan using the variance component ap-
proach implemented in the SOLAR program as previously
described [3]. All models run in SOLAR included age
(quartiles), sex (dichotomous), community group (dichot-
omous, inland vs. coastal), and δ15N value quartiles.
We tested all SNPs under the linkage peaks with a
LOD score greater than 1.5 for association with the trait
using ASSOC from the S.A.G.E. package, which models
the full correlation structure of the pedigree [7, 11]. All
association models included the same non-genetic covar-
iates that were used for the linkage analysis: sex, age,
community, and δ15N value quartiles. A sensitivity ana-
lysis additionally adjusted for the season of blood sample
collection as a categorical variable. For each SNP, the
following two models were run: one containing non-
genetic covariates and the SNP genotype as an additive
effect and one containing non-genetic covariates, SNP
genotype as an additive effect, and the interaction be-
tween SNP effect and δ15N value quartiles. Likelihood
ratio tests were used to compare the models. Correc-
tions for multiple testing were ascertained separately for
each linkage peak of interest, calculating the effective
number of tested SNPs (i.e., independent SNPs not in
linkage disequilibrium (LD)) using spectral decom-
position of the correlation matrix [23, 32]. Bonferroni
corrections for the effective number of SNPs in each
linkage peak were used to determine the number of
full model results that met the significance threshold
(Additional file 1: Table S1). Full models were defined
to include both the additive genotype term and the
interactions of that term with n-3 polyunsaturated fatty
acids (PUFA) intake.
Bioinformatic analysis
In order to limit the list of potential genes from regions
identified by linkage analysis (LOD score >1.5), we used
the SIMWALK2 [43] to phase the genotype data. This
analysis indicates the positions of recombination events
in the haplotypes of the analyzed individuals. We deter-
mined the haplotypes for each individual that had no
recombination events and included the position of
peak evidence for linkage with the trait of interest.The regions thus defined were examined for the full
sample, as well as the subsets limited to both the
highest and lowest quartile of the trait of interest. Re-
gions in which less than 5 % of the examined sample
experienced a recombination event were included in
subsequent bioinformatic analysis. This region was
very narrow for chromosome 3, so the threshold was
relaxed for that region. Within the regions, potential
candidate genes were identified using three comple-
mentary algorithms: Ingenuity (Qiagen, Redwood City,
CA), TOPPGene Suite [6], and ENDEAVOUR [44].
For all three algorithms, training gene lists were based
on the keyword “PTH” or “Vitamin D” in the HuGE navi-
gator [49]. Genes were selected if they attained a HuGE
score of at least 0.10 and were related to vitamin D and
PTH only. Gene names were converted to Ensembl using
BioMart Central ID converter as necessary. The settings
for all three algorithms were identical to those in a previ-
ous analysis by our group [45]. Genes were considered to
be putative candidates if the P values for both TOPPGene
and ENDEAVOUR were ≤0.005 and if they were shown
by Ingenuity to interact with the chosen training genes.
Results
Descriptive characteristics of the Yup’ik study participants
are presented in Table 1. All of the P values in this table
are based on simple two-sample t tests, without taking the
pedigree correlation into account. RBC δ15N values and
circulating PTH were both significantly higher among
women, while 25(OH)D levels did not vary by gender. The
correlation between serum 25(OH)D and PTH levels was
estimated at −0.09. Transformations of both traits reduced
residual kurtosis from 9.96 to 0.45 for PTH and from 4.00
to 1.10 for 25(OH)D. Heritability was estimated at
0.43 ± 0.07 for log-transformed PTH (P value = 1.2 ×
10−10) and at 0.54 ± 0.07 for Box-Cox transformed
25(OH)D (P value = 2.3 × 10−18).
Results for the genome-wide linkage scan are pre-
sented in Table 2 and Figs. 1 and 2. Three regions on
chromosomes 2, 10, and 22 yielded a LOD score of at
least 2 for 25(OH)D. The linkage peak on chromosome
2 exhibited the strongest signal, with the LOD score ex-
ceeding 4 for 25(OH)D. Also, three regions on chromo-
somes 3, 14, and 17 were linked with PTH with LOD
scores greater than 2.
After adjusting for multiple testing, two variants on
chromosome 2 and one variant on chromosome 10 were
significantly associated with 25(OH)D at adjusted α =
0.001 and 0.002, respectively, while only one variant on
chromosome 3 was significantly associated with PTH at
adjusted α = 0.001. However, the two variants on
chromosome 2 were in perfect LD. Significant SNPs and
the associated genes are presented in Table 3. Significant
interactions of variants on chromosome 2 with n-3
Table 1 Descriptive statistics of the study sample (n = 926)
Male Female P value
Na 419 (45) 507 (55) 0.004
Coastal community groupa 184 (50) 186 (50) 0.92
Inland community groupa 235 (42) 321 (58) 0.0003
Age, yearsb 36.56 (17.56) 38.07 (17.61) 0.17
δ15N, ‰b 8.80 (1.51) 9.13 (1.54) 0.0001
Parathyroid hormone, pg/mLc 52.7 (24.21–114.84) 65.60 (27.83–154.61) <0.0001
25(OH)D, ng/mLc 34.57 (11.47–83.32) 33.96 (12.21–77.69) 0.56
The overall study sample consists of 926 individuals after QC; however, two were missing values for 25(OH)D and two different individuals were missing values for
parathyroid hormone
aN = sample size (%), P value based on binomial distribution
bMean (SD), P value based on two-sample t test
cMean (95 % CI), P value based on two-sample t test
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evidence suggestive of similar interactions between a
variant on chromosome 3 and circulating PUFA in the
PTH models (Additional files 2 and 3: Figures S1 and S2).
Additional adjustment for season did not appreciably
change the observed genetic associations (data not shown).
Results of the bioinformatic analysis are summarized
in Table 4. None of the a priori identified training genes
were located under the linkage peaks. All peaks except
for the one on chromosome 2 contained candidate genes
proposed by all three bioinformatic algorithms.
Discussion
The CANHR Yup’ik study population is ideal for investi-
gation of the genetic determinants of circulating vitamin
D and potential gene-diet interactions with n-3 PUFA.
Despite low levels of sunlight exposure, mean 25(OH)D
levels in our study sample were well within the optimal
range currently recommended for the general population
[4]. This paradox may be explained by both genetic ad-
aptations as well as the high vitamin D content of the
traditional diet of the Yup’ik people, which may buffer
the effects of insufficient sunlight at higher latitudes
(reviewed by [15, 17]). Indeed, a previous analysis of a
CANHR subsample demonstrated that intake of locally
harvested foods, namely fatty fish, fish roe, fish liver, andTable 2 Linkage peaks with a LOD score >2
Chromosome bands Peak LOD score Start
25(OH)D
2p16.2–2p12 4.25 rs148
10p13–10p12.1 2.52 rs873
22q13.1–22q13.31 2.17 rs138
Parathyroid hormone
3q25.32–3q26.32 2.48 rs679
14q12–14q22.1 2.93 rs714
17p13.1–17p11.2 2.15 rs921wild game, is correlated with higher levels of 25(OH)D
[24]. Yet, another study showed that 25(OH)D mediates
PTH levels in our study population [25]. Using genotype
data from extended pedigrees, biochemical measure-
ments of 25(OH)D, PTH, and the δ15N value (a marker
of traditional diet rich in vitamin D), and established
biological pathways, this report further illustrates the
complexity of vitamin D metabolism in the Yup’ik
people.
Three linkage peaks were identified for 25(OH)D and
three for PTH. The peaks for the two traits did not over-
lap, reflecting distinct genetic contributions underlying
the weakly correlated 25(OH)D and PTH levels in our
study population as well as others [21, 39]. All were
novel findings except for the locus on chromosome 2,
which was initially reported as linked to 25(OH)D3 in
Northern European families with asthma [48] and asso-
ciated with bone mineral density in a large meta-analysis
[8]. Few genome-wide linkage studies on 25(OH)D and
none on PTH are available to use as a comparison.
Interestingly, none of our observed linkage regions con-
tained genes previously reported in genome-wide associ-
ation studies (GWAS) of 25(OH)D or 1,25(OH)2D, e.g.,
GC on chromosome 4 [1] or CYP2R1 and DHCR7 on
chromosome 11 [46]. Similarly, the previous GWAS as-
sociation of loci in the PTH gene with circulating PTHSNP End SNP Genomic region
3869 rs741418 52,906,147–75,363,186
849 rs638324 14,509,807–27,730,261
383 rs929090 38,799,861–44,313,849
9097 rs6443567 158,811,068–178,427,716
9108 rs735265 32,962,300–52,120,264
7 rs1037037 7,363,088–18,765,021
Fig. 1 Linkage results for vitamin D. Whole-genome linkage scan for circulating vitamin D in Yup’ik people (n= 924). The X-axis shows the chromosomal
location, and the Y-axis displays the LOD score
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may include our genotyping approach, which utilized a
linkage-specific panel that was not designed to include
all physiologically relevant loci, the uniqueness of our
population, and chance. The remaining linkage peaks at
10p13–p12.1 and 22q13.1–13.31 for 25(OH)D andFig. 2 Linkage results for parathyroid hormone. Whole-genome linkage sca
the chromosomal location, and the Y-axis displays the LOD score3q25.32–26.32, 14.12–22.1, and 17p13.1–11.2 for PTH
are novel and contain several biologically plausible loci.
Using complementary methods, bioinformatic analysis
identified several strong candidate genes located under
observed linkage peaks. Of those, the most notable is
CUBN (cubilin), located on chromosome 10. Then for parathyroid hormone in Yup’ik people (n = 924). The X-axis shows
Table 3 Significant associations under the linkage peaks
SNP Chr Gene P (additive)a P (full)b χ2 (LRT)c P (LRT)c
25(OH)D
rs10205487/rs897119d 2 MXD1 0.22 0.0006 18.15 0.0004
rs10828183 10 NEBL 0.0005 0.004 3.18 0.37
Parathyroid hormone
rs1353894 3 FNDC3B 0.03 0.0008 14.21 0.003
aP value for the model including age, sex, community group, δ15N quartiles, and additive genotype
bP value for the model including all of the above plus the interaction term between the additive genotype and δ15N quartiles
cChi-square statistic and P value for the likelihood ratio test comparing the additive model with the full model
drs10205487 and rs897119 were found to be in perfect linkage disequilibrium, with identical estimates of association signal
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delivery of 25(OH)D3 to kidney epithelial cells, impacting
circulating levels of the hormone [33]. In both human and
animals, mutations causing cubulin dysfunction are asso-
ciated with abnormal vitamin D metabolism (e.g., urinary
excretion of 25(OH)D3 in humans) [33]. Another biologic-
ally interesting finding from the bioinformatic analysis is
MGAT3 (beta-1,4-mannosyl-glycoprotein 4-beta-N-acetyl-
glucosaminyltransferase), located on chromosome 22.
MGAT3 encodes an enzyme implicated in protein glyco-
sylation and the immune response [20]. Preliminary data
illustrate MGAT3 mRNA as a potential biomarker of re-
sponse to vitamin D therapy in Alzheimer’s disease, hinting
at its translational potential; however, these findings remain
to be independently validated [9]. Isoforms of two other
potential candidate genes, CACNA1I (calcium channel,
voltage-dependent, T type, alpha 1i subunit) and PDGFB
(plate-derived growth factor beta polypeptide), have been
shown to be regulated by the vitamin D receptor, respect-
ively affecting calcium homeostasis [12] and mitosis [36].
Several strong candidate genes for PTH were also iden-
tified based on their involvement in relevant physiological
pathways. NFKBIA (nuclear factor kappa light polypeptide
gene enhancer in B cells inhibitor, alpha) is a member of
the NFkB inhibitor family that binds with the product of
REL (v-rel reticuloendotheliosis viral oncogene homolog,Table 4 Potential candidate genes identified by bioinformatic
analysis of genes within linkage peaks for 25(OH)D and
parathyroid hormone
Chromosome bands Putative candidate genes
25(OH)D
10p13–10p12.1 CUBN, RSU1
22q13.1–22q13.31 APOBEC3F, APOBEC3G, ATF4, CACNA1I,
CBX7, CBY1, DDX17, DMC1, GTPBP1,
MGAT3, PDGFB, RPL3
Parathyroid hormone
3q25.32–3q26.32 NLGN1
14q12–14q22.1 CFL2, FOXA1, MYH1, NFKBIA, NKX2-8,
PAX9, PSMA6, SFTA3, SNX6
17p13.1–17p11.2 GAS7, MIPOL1, MYH2, MYH4, RCVRNregulated by the vitamin D receptor) to inhibit Rel/NFkB
complexes. In a previous transcriptome-wide study, the
expression of NFKBIA in white blood cells was shown to
be decreased by vitamin D supplementation, potentially
affecting downstream immune response [18]. Reflecting
the pleiotropic functions of the vitamin D/PTH axis, other
potential candidate genes were also implicated immune/
inflammatory processes (NKX2, PSMA6, SNX6) as well as
cancer (NKX2, NKX3, PAX9).
Extended pedigrees such as those present in the
CANHR study provide a powerful framework for tar-
geted association following whole-genome linkage [47].
Targeted association analysis of the observed linkage
peaks identified two SNPs in MXD1 (MAX dimerization
protein 1) and one in NEBL (nebulette) that were signifi-
cantly associated with 25(OH)D levels and one in
FNDC3B (fibronectin type III domain containing 3B) as-
sociated with PTH levels. Both MXD1 and FNDC3B are
involved in the VDR/RXR activation pathway, the former
being regulated by the vitamin D/VDR/RXR complex
[38] and the latter suppressing the expression of RUNX2
[19], which in turn binds to and activates vitamin D/
VDR/RXR [35]. On the other hand, NEBL has been im-
plicated in calcium homeostasis [26], although a direct
link to vitamin D metabolism has not been investigated.
This study presents novel evidence of linkage be-
tween several biologically plausible genomic regions
and 25(OH)D/PTH in a study population of Yup’ik
people with seasonally low exposure to sunlight and
high intake of vitamin D-rich foods. These findings
are particularly informative in the context of the vitamin
D/VDR/RXR pathway, which illustrates the involvement
of candidate loci in maintaining the vitamin D/PTH/cal-
cium homeostasis. To our knowledge, this is the first
whole-genome linkage study of PTH overall and the first
such study of both phenotypes in a circumpolar popula-
tion. In addition to replicating a previously reported link-
age region for 25(OH)D and identifying novel loci for both
25(OH)D and PTH, we present novel evidence of gene-
diet interactions with n-3 PUFA intake. Specifically, a vari-
ant in MXD1 was significantly associated with 25(OH)D
only after accounting for its interaction with δ15N, a
Aslibekyan et al. Genes & Nutrition  (2016) 11:23 Page 7 of 8marker of n-3 PUFA intake and traditional lifestyle in
Yup’ik people. To the best of our knowledge, no other
circumpolar cohorts currently have comparable genotypic
and phenotypic measurements, limiting our opportunities
for external replication. Future studies in high-latitude
populations with unique vitamin D dietary sources and
requirements are warranted to establish validity of our
findings, laying the groundwork for disease-prevention
efforts in Arctic communities.
Conclusions
We provide evidence of linkage between several biologic-
ally plausible genomic regions, located on chromosomes
2, 3, 10, 14, 17, and 22, and vitamin D metabolism in a
circumpolar population. Additionally, these findings
suggest that the traditional dietary pattern of the Yup’ik
people, characterized by high intake of n-3 PUFA, may
modulate genetic effects on circulating 25(OH)D.
Endnotes
1There was only one 13 year old individual, who turned
14 within two weeks of enrollment.
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